Byrne, M J <br/><br/>
Recirculating cardiac delivery of AAV2/1SERCA2a improves myocardial function in an experimental model of heart failure in large animals.  [electronic resource] 

 -  Gene therapy  Dec 2008 
 - 1550-7 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1476-5462 
<br/><br/><label>Standard No.: </label>10.1038/gt.2008.120  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Cardiac Pacing, Artificial<br/>Coronary Circulation<br/>Dependovirus--genetics<br/>Dose-Response Relationship, Drug<br/>Echocardiography<br/>Gene Expression<br/>Genetic Therapy--methods<br/>Genetic Vectors--administration & dosage<br/>Heart Failure--metabolism<br/>Liver--virology<br/>Lung--virology<br/>Models, Animal<br/>Myocardium--metabolism<br/>Polymerase Chain Reaction--methods<br/>RNA, Messenger--analysis<br/>Random Allocation<br/>Sarcoplasmic Reticulum Calcium-Transporting ATPases--blood<br/>Sheep<br/>Time<br/>Transduction, Genetic--methods<br/>Transgenes